TFM 735Alternative Names: TFM-735
Latest Information Update: 23 Nov 2016
At a glance
- Originator Mochida Pharmaceutical
- Class Small molecules
- Mechanism of Action NF E2 related factor 2 stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Multiple sclerosis